2026-06-30T01:53:55Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/71632024-09-27T09:38:38Zcom_20.500.12105_19604com_20.500.12105_2051col_20.500.12105_19605

00925njm 22002777a 4500 dc Fernandez-Friera, Leticia author Salguero, Rafael author Vannini, Luca author Argüelles, Ana Fidalgo author Arribas, Fernando author Solis, Jorge author 2018-03-14 Mitral valve prolapse (MVP) is a common and benign condition. However, some anatomic forms have been recently associated with life-threatening ventricular arrhythmias and sudden cardiac death. Imaging MVP holds the promise of individualized MVP risk assessment. Noninvasive imaging techniques available today are playing an increasingly important role in the diagnosis, prognosis and monitoring of MVP. In this article, we will review the current evidence on arrhythmogenic MVP, with special focus on the utility of echocardiography and CMR for identifying benign and "malignant" forms of MVP. The clinical relevance of this manuscript lies in the value of imaging technology to improve MVP risk prediction, including those arrhythmic-MVP cases with a higher risk of sudden cardiac death. Glob Cardiol Sci Pract. 2018; 2018(1):4 10.21542/gcsp.2018.4 2305-7823 Global cardiology science & practice 29644231 http://hdl.handle.net/20.500.12105/7163 Mechanistic insights of the left ventricle structure and fibrosis in the arrhythmogenic mitral valve prolapse